I read with great interest the recent article by Parseghian and colleagues ([1][1]), presenting a review of the mechanisms underlying the innate and acquired resistance to anti-EGFR therapy. This “in-depth review” of the resistance mechanisms, however, does not include the possible host antibody

中文翻译：

---

先天性和后天性抗EGFR治疗耐药性

我非常感兴趣地阅读了Parseghian和同事的最新文章（[1] [1]），该文章对先天性和获得性抗EGFR治疗的潜在机制进行了综述。但是，这种对耐药机制的“深入综述”并未包括可能的宿主抗体